These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31100268)

  • 1. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
    Bangaru S; Lang S; Schotsaert M; Vanderven HA; Zhu X; Kose N; Bombardi R; Finn JA; Kent SJ; Gilchuk P; Gilchuk I; Turner HL; García-Sastre A; Li S; Ward AB; Wilson IA; Crowe JE
    Cell; 2019 May; 177(5):1136-1152.e18. PubMed ID: 31100268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.
    Watanabe A; McCarthy KR; Kuraoka M; Schmidt AG; Adachi Y; Onodera T; Tonouchi K; Caradonna TM; Bajic G; Song S; McGee CE; Sempowski GD; Feng F; Urick P; Kepler TB; Takahashi Y; Harrison SC; Kelsoe G
    Cell; 2019 May; 177(5):1124-1135.e16. PubMed ID: 31100267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
    Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
    Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
    Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody.
    Yan L; Wang H; Sun L; Liu Y; Sun J; Zhao X; Li Y; Xie X; Hu J
    Biochem Biophys Res Commun; 2019 Oct; 518(2):319-324. PubMed ID: 31421820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.
    Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
    Sautto GA; Kirchenbaum GA; Abreu RB; Ecker JW; Pierce SR; Kleanthous H; Ross TM
    J Immunol; 2020 Jan; 204(2):375-385. PubMed ID: 31811019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.
    Kim MC; Lee YN; Kim YJ; Choi HJ; Kim KH; Lee YJ; Kang SM
    Antiviral Res; 2017 Dec; 148():43-52. PubMed ID: 29107058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.
    Laursen NS; Friesen RHE; Zhu X; Jongeneelen M; Blokland S; Vermond J; van Eijgen A; Tang C; van Diepen H; Obmolova G; van der Neut Kolfschoten M; Zuijdgeest D; Straetemans R; Hoffman RMB; Nieusma T; Pallesen J; Turner HL; Bernard SM; Ward AB; Luo J; Poon LLM; Tretiakova AP; Wilson JM; Limberis MP; Vogels R; Brandenburg B; Kolkman JA; Wilson IA
    Science; 2018 Nov; 362(6414):598-602. PubMed ID: 30385580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.
    Yu F; Song H; Wu Y; Chang SY; Wang L; Li W; Hong B; Xia S; Wang C; Khurana S; Feng Y; Wang Y; Sun Z; He B; Hou D; Manischewitz J; King LR; Song Y; Min JY; Golding H; Ji X; Lu L; Jiang S; Dimitrov DS; Ying T
    Cell Host Microbe; 2017 Oct; 22(4):471-483.e5. PubMed ID: 28966056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.